Accountable Care Organizations
Accountable Care Organizations (ACOs) provide coordinated care to patients in hopes of limiting costs and providing a better linking of services. Through these network of services, patients can be ensured they are getting the highest quality care while also limiting unnecessary tests and procedures.
Understanding Your Market Challenges
Workflow standardization is an important challenge ACOs are faced with. BlueNovo clinical liaisons help ACOs transition to standardized data input processes that affect accurate reporting downstream.
ACOs have multiple touch points for patient care. BlueNovo partners with ACOs to assist with optimizing Health IT operations while aiming to align to the goal of efficient coordinated care.
Data management is critical for the modern healthcare organization, small or large. BlueNovo’s Analytics team works with ACOs to maximize reporting capabilities based on data input by staff.
Population Health Management
It is important to be able to make patient data actionable. BlueNovo provides the expertise to ACOs to help them make sense of their data and how it can be used in coordination with Quality Improvement initiatives.
New Infrastructure Technologies
As new technologies emerge, organizations are left with decisions to adapt or risk falling behind. The BlueNovo IT team works with ACOs to eliminate guess work around technology investments, advising on what is needed, when it is needed and associated cost models.
Healthcare organizations have extensive and continuously growing data sets that need to be protected around the clock. The BlueNovo Cybersecurity team works with organizations to implement the security strategy and structure necessary to promote safety against internal and external threats.
How can we help?
Latest news in the industry
Watch Series 4 Receives First FDA Clearance For Apple Apple is paving the way for more consumer medical gadgets as they received FDA clearance for both an atrial-fibrillation detecting algorithm and an ECG that will be built into the new watch. The FDA is eager to...